The PSP-subcortical group had a more benign clinical trajectory, less cognitive impairment, lower serum NF-L levels, higher TRIM11 rs564309 minor allele frequency, and more restricted midbrain and cortical atrophy than the PSP-RS and PSP-cortical groups. The gene discussed is NEFL; the disease is Cognitive impairment.